Literature DB >> 23148316

Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice.

Kush Paul1, Deepa V Venkitaramani, Charles L Cox.   

Abstract

Fragile X syndrome (FXS) is the most common form of inheritable mental retardation caused by transcriptional silencing of the Fmr1 gene resulting in the absence of fragile X mental retardation protein (FMRP). The role of this protein in neurons is complex and its absence gives rise to diverse alterations in neuronal function leading to neurological disorders including mental retardation, hyperactivity, cognitive impairment, obsessive-compulsive behaviour, seizure activity and autism. FMRP regulates mRNA translation at dendritic spines where synapses are formed, and thus the lack of FMRP can lead to disruptions in synaptic transmission and plasticity. Many of these neurological deficits in FXS probably involve the prefrontal cortex, and in this study, we have focused on modulatory actions of dopamine in the medial prefrontal cortex. Our data indicate that dopamine produces a long-lasting enhancement of evoked inhibitory postsynaptic currents (IPSCs) mediated by D1-type receptors seen in wild-type mice; however, such enhancement is absent in the Fmr1 knock-out (Fmr1 KO) mice. The facilitation of IPSCs produced by direct cAMP stimulation was unaffected in Fmr1 KO, but D1 receptor levels were reduced in these animals. Our results show significant disruption of dopaminergic modulation of synaptic transmission in the Fmr1 KO mice and this alteration in inhibitory activity may provide insight into potential targets for the rescue of deficits associated with FXS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148316      PMCID: PMC3591719          DOI: 10.1113/jphysiol.2012.241067

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  48 in total

1.  Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning.

Authors:  G E Schafe; C M Atkins; M W Swank; E P Bauer; J D Sweatt; J E LeDoux
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Inference deficits in women with Fragile X Syndrome: A problem in working memory.

Authors:  Janice M Keenan; Jodie A Simon
Journal:  Cogn Neuropsychol       Date:  2004-09-01       Impact factor: 2.468

3.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Authors:  Susheel Vijayraghavan; Min Wang; Shari G Birnbaum; Graham V Williams; Amy F T Arnsten
Journal:  Nat Neurosci       Date:  2007-02-04       Impact factor: 24.884

4.  Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory.

Authors:  S G Rao; G V Williams; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

5.  Nature of the working memory deficit in fragile-X syndrome.

Authors:  F Munir; K M Cornish; J Wilding
Journal:  Brain Cogn       Date:  2000-12       Impact factor: 2.310

6.  Differential impact of the FMR-1 full mutation on memory and attention functioning : a neuropsychological perspective.

Authors:  K M Cornish; F Munir; G Cross
Journal:  J Cogn Neurosci       Date:  2001-01-01       Impact factor: 3.225

7.  Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function.

Authors:  J E Roberts; F J Symons; A-M Johnson; D D Hatton; M L Boccia
Journal:  J Intellect Disabil Res       Date:  2005-09

8.  Working memory in individuals with fragile X syndrome.

Authors:  Silvia Lanfranchi; Cesare Cornoldi; Sibilla Drigo; Renzo Vianello
Journal:  Child Neuropsychol       Date:  2008-06-12       Impact factor: 2.500

9.  Neocortical excitation/inhibition balance in information processing and social dysfunction.

Authors:  Ofer Yizhar; Lief E Fenno; Matthias Prigge; Franziska Schneider; Thomas J Davidson; Daniel J O'Shea; Vikaas S Sohal; Inbal Goshen; Joel Finkelstein; Jeanne T Paz; Katja Stehfest; Roman Fudim; Charu Ramakrishnan; John R Huguenard; Peter Hegemann; Karl Deisseroth
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

Review 10.  Differential regulation of fronto-executive function by the monoamines and acetylcholine.

Authors:  T W Robbins; A C Roberts
Journal:  Cereb Cortex       Date:  2007-09       Impact factor: 5.357

View more
  13 in total

1.  Hyperactivity, perseveration and increased responding during attentional rule acquisition in the Fragile X mouse model.

Authors:  Ioannis Kramvis; Huibert D Mansvelder; Maarten Loos; Rhiannon Meredith
Journal:  Front Behav Neurosci       Date:  2013-11-21       Impact factor: 3.558

2.  Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome.

Authors:  Tiffany D Rogers; Allison M J Anacker; Travis M Kerr; C Gunnar Forsberg; Jing Wang; Bing Zhang; Jeremy Veenstra-VanderWeele
Journal:  Mol Autism       Date:  2017-06-23       Impact factor: 7.509

3.  Of Men and Mice: Modeling the Fragile X Syndrome.

Authors:  Regina Dahlhaus
Journal:  Front Mol Neurosci       Date:  2018-03-15       Impact factor: 5.639

4.  Cortical Excitation:Inhibition Imbalance Causes Abnormal Brain Network Dynamics as Observed in Neurodevelopmental Disorders.

Authors:  Marija Markicevic; Ben D Fulcher; Christopher Lewis; Fritjof Helmchen; Markus Rudin; Valerio Zerbi; Nicole Wenderoth
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

Review 5.  Differential effects of dopamine-directed treatments on cognition.

Authors:  F Gregory Ashby; Vivian V Valentin; Stella S von Meer
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-29       Impact factor: 2.570

Review 6.  Increasing our understanding of human cognition through the study of Fragile X Syndrome.

Authors:  Denise Cook; Erin Nuro; Keith K Murai
Journal:  Dev Neurobiol       Date:  2013-07-30       Impact factor: 3.964

Review 7.  Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Authors:  Hansen Wang; Sandipan Pati; Lucas Pozzo-Miller; Laurie C Doering
Journal:  Front Cell Neurosci       Date:  2015-02-26       Impact factor: 5.505

8.  Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit.

Authors:  W M Kenkel; J R Yee; K Moore; D Madularu; P Kulkarni; K Gamber; M Nedelman; C F Ferris
Journal:  Transl Psychiatry       Date:  2016-03-22       Impact factor: 6.222

Review 9.  The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids.

Authors:  Joris H J van Sadelhoff; Paula Perez Pardo; Jiangbo Wu; Johan Garssen; Jeroen van Bergenhenegouwen; Astrid Hogenkamp; Anita Hartog; Aletta D Kraneveld
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-16       Impact factor: 5.555

10.  Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism.

Authors:  Owen Y Chao; Salil S Pathak; Hao Zhang; Nathan Dunaway; Jay-Shake Li; Claudia Mattern; Susanne Nikolaus; Joseph P Huston; Yi-Mei Yang
Journal:  Mol Brain       Date:  2020-08-10       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.